Outcomes11

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 11 of 11

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Cumulative Number of Subjects With Any of the Components of the Composite Endpoint: >2kg Increase in Body Weight (Office-based), >2 L Increase in Total Body Water, Increase in 2 or More Loop-diuretic Equivalents, Fluid Retention Adverse Event (AE)	baseline to Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis.~For intercurrent events treatment policy strategy was used. No imputation was performed.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Change From Baseline in Body Weight	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	kg	LEAST_SQUARES_MEAN
SECONDARY	Change From Baseline in Body Fat Mass	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	kg	LEAST_SQUARES_MEAN
SECONDARY	Change From Baseline in Total Body Water	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	L	LEAST_SQUARES_MEAN
SECONDARY	Change From Baseline in Extracellular Water Volume	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	L	LEAST_SQUARES_MEAN
SECONDARY	Change From Baseline in Intracellular Water Volume	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	L	LEAST_SQUARES_MEAN
SECONDARY	Change in Body Weight (kg) Over Time Course of Study	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	kg	LEAST_SQUARES_MEAN
SECONDARY	Change in Total Dosage of Loop-diuretic Equivalents Use	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	Loop-diuretic mg equivalent	LEAST_SQUARES_MEAN
SECONDARY	Cumulative Number of Subjects With Either of the Two Components of This Composite: 1. >3 L Increase in Total Body Water Volume From Baseline to Week 6 2. Increase in 3 or More Loop-diuretics Equivalents Use	from baseline to Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis.~For intercurrent events treatment policy strategy was used. No imputation was performed.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Absolute Change in Systolic Blood Pressure	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	mmHg	LEAST_SQUARES_MEAN
SECONDARY	Absolute Change in Diastolic Blood Pressure	at Week 6	All randomised subjects who received at least one dose of treatment are included in the analysis. For intercurrent events treatment policy strategy was used. No imputation was performed.	mmHg	LEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06269484/outcomes

API reference For AI assistants